Deciphering the regulatory role of matricelluar protein CCN3 in functional collateral blood flow

解读基质细胞蛋白CCN3在功能性侧支血流中的调节作用

基本信息

  • 批准号:
    10371083
  • 负责人:
  • 金额:
    $ 51.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Peripheral artery disease (PAD) affects more than 200 million adults worldwide. Critical limb ischemia (CLI), the most advanced form of PAD, causes significant morbidity, mortality, and health care resource utilization. Despite our increased understanding of the pathobiology of PAD, medical treatments remain inadequate and revascularization (surgical and non-surgical) or amputation are unfortunately the major therapeutic options. Therefore, it is imperative to address this important unmet clinical need, potentially by the development of novel pharmacologic therapies combined with more effective management strategies. However, current efforts in these areas are significantly hindered due to incomplete knowledge of the fundamental mechanisms that govern the dysregulation of vascular function, as well as the failure to generate an effective vascular network to restore flow. Our recent observations have identified CCN3 (Nov), a specific member of the matricellular protein family, CCN (Cyr61, Ctgf, Nov), as an important regulator of endothelial function in the context of neovascularization. CCN3 expression was found to be strongly reduced in limb tissues from CLI patients. In a murine hind limb ischemia (HLI) model, global CCN3 deficiency resulted in enhanced necrosis concomitant with decreases in tissue reperfusion, hypoxia-induced factor (HIF) signaling and VEGF-A production - key mechanisms responsible for the loss of functional collateral blood flow in PAD. Additionally, cell-type specific deletion of CCN3 in mice and preliminary cell-based studies indicate that endothelial cell CCN3 deficiency plays a major role in the impairment of blood flow recovery. Restrictive deletion of CCN3 in the endothelium phenocopies the effects of the global CCN3 knockout. This strongly suggests that endothelial CCN3 is a positive regulator of collateral blood flow recovery following HLI. At the cellular level, loss of CCN3 results in impaired endothelial migration and tube formation, pivotal processes involved in angiogenesis requisite for blood flow recovery. Collectively, these observations led to the central hypothesis that CCN3 serves as a critical physiological regulator in driving neovascularization and the attendant tissue perfusion. In Aim 1, we will fully characterize the role of CCN3 in the regulation of collateral blood flow. Aim 2 is designed to elucidate the mechanisms by which CCN3 deficiency leads to compromised neovascularization and collateral blood flow. Finally, in Aim 3, we plan to explore the therapeutic potential of CCN3 in preclinical models of limb ischemia. The results of these studies will elucidate the role of CCN3 in controlling endothelial function in ischemia and the mechanisms underlying its ability to promote neovascularization and functional collateral blood flow.
项目概要 外周动脉疾病 (PAD) 影响着全球超过 2 亿成年人。严重肢体缺血(CLI), PAD 的最高级形式,导致显着的发病率、死亡率和医疗资源利用率。 尽管我们对 PAD 病理学的了解不断加深,但药物治疗仍然不足且 不幸的是,血运重建(手术和非手术)或截肢是主要的治疗选择。 因此,必须解决这一重要的未满足的临床需求,可能通过开发 新的药物疗法与更有效的管理策略相结合。然而,目前 由于对基本机制的了解不完全,这些领域的努力受到严重阻碍 控制血管功能失调,以及无法产生有效的血管 网络恢复流量。我们最近的观察发现了 CCN3(11 月),它是 基质细胞蛋白家族 CCN (Cyr61, Ctgf, Nov),作为内皮功能的重要调节因子 新生血管形成的背景。 CLI 发现肢体组织中 CCN3 表达显着降低 患者。在小鼠后肢缺血 (HLI) 模型中,整体 CCN3 缺乏导致坏死加剧 伴随组织再灌注、缺氧诱导因子 (HIF) 信号传导和 VEGF-A 的减少 产生——导致 PAD 功能性侧支血流丧失的关键机制。此外, 小鼠中 CCN3 的细胞类型特异性缺失和初步细胞研究表明内皮细胞 CCN3 缺乏在血流恢复受损中起着重要作用。限制性删除CCN3 内皮表型复制了全局 CCN3 敲除的影响。这强烈表明内皮细胞 CCN3 是 HLI 后侧支血流恢复的正调节因子。在细胞水平上,CCN3 的缺失 导致内皮迁移和管形成受损,这是血管生成的关键过程 血流恢复的必要条件。总的来说,这些观察结果得出了一个中心假设:CCN3 作为驱动新血管形成和随之而来的组织灌注的关键生理调节剂。在 目标1,我们将充分表征CCN3在侧支血流调节中的作用。目标2已设计 阐明 CCN3 缺乏导致新血管形成受损的机制 侧支血流。最后,在目标 3 中,我们计划探索 CCN3 在临床前的治疗潜力 肢体缺血模型。这些研究的结果将阐明CCN3在控制中的作用 缺血中的内皮功能及其促进新生血管形成的机制 功能性侧支血流。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhiyong Lin其他文献

Zhiyong Lin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhiyong Lin', 18)}}的其他基金

Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
  • 批准号:
    10504077
  • 财政年份:
    2022
  • 资助金额:
    $ 51.05万
  • 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
  • 批准号:
    10662518
  • 财政年份:
    2022
  • 资助金额:
    $ 51.05万
  • 项目类别:
Deciphering the regulatory role of matricelluar protein CCN3 in functional collateral blood flow
解读基质细胞蛋白CCN3在功能性侧支血流中的调节作用
  • 批准号:
    10594955
  • 财政年份:
    2020
  • 资助金额:
    $ 51.05万
  • 项目类别:
Role of Protein Phosphatase 2A in Aortic Aneurysm
蛋白磷酸酶 2A 在主动脉瘤中的作用
  • 批准号:
    10317079
  • 财政年份:
    2019
  • 资助金额:
    $ 51.05万
  • 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
  • 批准号:
    9212759
  • 财政年份:
    2014
  • 资助金额:
    $ 51.05万
  • 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
  • 批准号:
    9000080
  • 财政年份:
    2014
  • 资助金额:
    $ 51.05万
  • 项目类别:
KLF15 and circadian regulation of alcohol-induced liver injury
KLF15 与酒精性肝损伤的昼夜节律调节
  • 批准号:
    8576602
  • 财政年份:
    2014
  • 资助金额:
    $ 51.05万
  • 项目类别:
CCN3 and aortic aneurysm
CCN3 和主动脉瘤
  • 批准号:
    8851671
  • 财政年份:
    2013
  • 资助金额:
    $ 51.05万
  • 项目类别:
CCN3 and aortic aneurysm
CCN3 和主动脉瘤
  • 批准号:
    8470031
  • 财政年份:
    2013
  • 资助金额:
    $ 51.05万
  • 项目类别:
CCN3 and aortic aneurysm
CCN3 和主动脉瘤
  • 批准号:
    8669158
  • 财政年份:
    2013
  • 资助金额:
    $ 51.05万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 51.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了